Skip to content

Effects of Play Based Therapy on Attention Level of Children With Down Syndrome

Effects of Play Based Therapy on Attention Level of Children With Down Syndrome

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06893666
Enrollment
20
Registered
2025-03-25
Start date
2025-03-28
Completion date
2025-07-09
Last updated
2025-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Down Syndrome

Keywords

Play Therapy, Down Syndrome, Attention, Randomized Control Trial, Child Development

Brief summary

The aim of the study is to examine the attention level of children with down syndrome receiving play based therapy as compared to children receiving child centered play therapy.

Interventions

Experimental group was given pay based therapy. Total of 4 sessions were given each session of 40min.

OTHERChild centered play therapy

Control group was given child centered play therapy. Total of 4 sessions were given each session of 40min.

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
3 Years to 5 Years
Healthy volunteers
No

Inclusion criteria

* Age: 3-5 years * Gender: Both male and female * Children who are currently taking speech therapy sessions with parental involvement. * Medically stable children with no severe ongoing health issues that could interfere with their participation in the study.

Exclusion criteria

* Children with severe sensory impairments * Co-morbid neurological conditions that may confound the results * Children who received intervention from any other institute

Design outcomes

Primary

MeasureTime frameDescription
NHS Attention and Listening ScreenerBaseline and 4 weeksThe screener was designed to measure attention and listening of children. It is dichotomous (yes/no) comprising of 9 items according to age rang of 3-5 years.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026